Row concave Shape Decorative svg added to bottom

Built to Be Your High Performance Site Partner

Monroe Biomedical Research (MBR) is the site organization built to give you a more reliable path from startup through closeout.

Across four fully owned sites, MBR supports Phase 1–4 trials with specialized depth in cardiometabolic, endocrinology, respiratory, vaccine, psychiatry, general medicine, and other therapeutic areas.

Doctor_Explaining_Blood_Pressure_Results
sites across three states
+
clinical trials conducted
+
participants enrolled

Fully Owned Sites. Centralized Operations.

Principal_Investigator_and_Site_Director

If you've worked with research site networks, you know that it's about more than access. When every networked site is directly owned and operated, you get alignment.

MBR coordinates contracting, budgets, startup, regulatory support, participant recruitment, data support, and quality oversight through one centralized operating infrastructure.

For you, that means clear accountability and a more consistent study experience from award through closeout.

Speed and Control

Site_Business_Meeting_Staff

MBR is built to compress startup timelines without cutting corners.

Centralized teams support faster budget and contract turnaround, coordinated regulatory submissions, and parallel startup activity when appropriate.

The result is a more efficient path to activation, first participant in, and study conducted thereafter.

Simplicity for Your Complex Trials

Blood_Draw

Complex trials need sites that can handle the operational weight.

MBR supports demanding study designs across the network, including serial sampling, infusion, diagnostics, combination product research, intensive visit schedules, and early-phase protocols.

The Monroe campus adds dedicated overnight and Phase 1 capabilities, while Louisville and Charleston bring specialty depth in metabolic and respiratory research.

Recruitment as a Core Operational Function

Women_Applauding_At_Event

Enrollment is often an afterthought for sites. A last-mile tactic that's often outsourced.

MBR is invested in directly engaging participants — outreach teams, active participant databases, community engagement, and prescreening workflows are embedded into site operations.

That structure helps your trial reach the right participants faster, support retention, and improve representation with greater intention.

A Happier Experience for Participants

Patient_Smiling_At_Nurse

MBR is built around the idea that participant experience is operationally important.

Comfortable facilities, responsive communication, engaged site teams, and trust-based recruitment help reduce avoidable friction throughout the study.

For your researfch program, that can mean stronger retention, better visit compliance, and smoother day-to-day execution.

Full Alignment With Your Team and Your Research Program

Colleagues_Casual_Meeting

For Large Pharma and CROs

You need scalable site execution without unnecessary variability.

MBR gives your study team one coordinated partner across fully owned sites, aligned processes, therapeutic depth, recruitment infrastructure, and purpose-built facilities for both specialty and general medicine programs.

For Startups/Biotechs

Lean teams need site partners that can anticipate what comes next. That's MBR.

MBR provides experienced site leadership, startup support, recruitment readiness, and operational coordination that help your team move with confidence from feasibility through closeout.

Therapeutic Experitise

Therapeutic Capabilities

  • Addiction
  • Allergy and Immunology
  • Autoimmune
  • Cardiometabolic
  • Cardiovascular
  • Critical Care
  • Diagnostics
  • Endocrinology and Metabolic Disorders
  • Family Medicine
  • Gastrointestinal
  • Infectious Disease
  • Internal Medicine
  • MASH/MASLD
  • Medical Devices and Wearables
  • Nephrology
  • Neurology
  • Obesity and Weight Management
  • Pain
  • Preventive Medicine
  • Psychiatry and Mental Health
  • Respiratory (Pulmonology, Asthma, and COPD)
  • Sample and Specimen Collection
  • Sleep Medicine
  • Vaccines

Specialized Trial Capabilities

MBR supports a range of specialized protocol requirements across the network, including:

  • Phase 1 and overnight studies
  • Serial PK/PD sampling
  • Controlled-substance research infrastructure
  • Infusion capabilities
  • Combination product studies
  • Diagnostic-device and drug-device protocols
  • On-site laboratory processing
  • Temperature-controlled investigational product storage
  • Pulmonary function testing
  • Ambulatory blood pressure monitoring
  • DEXA and FibroScan access
  • Pharmacy support for preparation, blinding, and storage

Areas of Excellence

Leading investigators.
Experienced sites.
Proven execution.

Principal_Investigator_Patient

Phase 1 Research

MBR’s Monroe campus is purpose-built for complex early-phase work, including first-in-human, dose-escalation, crossover, adaptive, vaccine, and other protocol-intensive studies requiring confinement, serial PK/PD collection, or overnight stays.

Doctor_Consulting_Patient_Exam_Room

Cardiomatabolic and Endocrinology

Across Monroe, Louisville, and Charleston, MBR offers strong depth in diabetes, obesity, metabolic disorders, hypertension, lipid disorders, and broader cardiometabolic studies.

Nurse_Examining_Elderly_Patient

Respiratory

Charleston brings particular strength in pulmonology, asthma, COPD, smoking-related studies, vaccines, and respiratory-focused general medicine protocols.

Doctor_Showing_Clipboard_To_Patient

MASH/MASLD

Louisville brings industry-leading experience in obesity, fatty liver disease, lipid disorders, and related cardiometabolic indications.

Site_Director_Participant

General Medicine at Scale

Beyond specialty depth, MBR supports high-volume general medicine studies through centralized processes, experienced investigators, and recruitment infrastructure built for consistent performance.

Built to Uphold a Higher Standard

Our Sites

Every MBR site is directly owned, staffed, and operated. That means shared infrastructure, aligned teams, consistent standards, and greater control across your trial.

  • Charleston, SC

    Monroe Biomedical Research, 4975 Lacross Road, Suite 200-B, North Charleston, SC 29406
    MBR Charleston is a respiratory-focused clinical research site with strong internal medicine capabilities, specialized staff, and rapid startup support.
  • Louisville, KY

    Monroe Biomedical Research, 3288 Illinois Avenue, Louisville, KY 40213
    MBR’s Louisville site is a prolific metabolic research facility with Phase 1–4 capabilities and strong central operational support.
  • Monroe, NC (East Building)

    Monroe Biomedical Research, 343 Venus St, Monroe, NC 28112
    MBR’s Monroe East Building is a dedicated overnight and early-phase research facility with Phase 1 infrastructure, serial sampling support, and 24-hour operational coverage.
  • Monroe, NC (West Building)

    Monroe Biomedical Research, 343 Venus St, Monroe, NC 28112
    MBR’s Monroe West Building is a high-efficiency outpatient clinical research site supported by Monroe campus infrastructure, quality systems, and recruitment resources.

Featured Investigators

MBR's principal investigators are clinically engaged physicians with research experience, therapeutic depth, and established participant relationships.

  • Awawu E. Igbinadolor, MD

    Dr. Awawu E. Igbinadolor is a highly accomplished Principal Investigator with broad experience across internal medicine clinical trials. At Monroe Biomedical Research, she has led studies across respiratory disease, diabetes, hypertension, Alzheimer’s disease, and COVID-19 research. She has completed more than 100 trials across diverse therapeutic areas and is experienced with first-in-human, dose-escalation, SAD/MAD, crossover, and adaptive designs in early Phase 1 trials. Dr. Igbinadolor is a strong fit for general medicine trials, with deep experience in cardiometabolic, endocrine, respiratory, infectious disease, vaccine, and early-phase studies.
  • Claire Presswood, MD

    Claire Presswood, MD, is a board-certified Internal Medicine physician, Diplomate of the American Board of Obesity Medicine, and Principal Investigator with years of clinical trial experience. She has been an investigator on over 100 clinical trials, with research interests in obesity, diabetes, post-bariatric hypoglycemia, hypertension, hyperlipidemia, cardiovascular outcomes, MASH, vaccines, devices, healthy participant studies, and Phase 1-3 clinical trials.
  • Gregory Feldman, MD, CPI

    Gregory Feldman, MD, is a triple-board-certified physician in Internal Medicine, Critical Care, and Pulmonology, with more than 30 years of experience working with pulmonary patients in clinical trials. Since 2007, he has completed more than 200 studies, with particular depth in respiratory, vaccine, and cardiometabolic research. He leads MBR Charleston as Principal Investigator and is a standout respiratory and pulmonology investigator.
  • Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC

    Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC, has served as Principal Investigator for more than 700 clinical trials of metabolic therapeutic interventions and is one of the strongest scientific differentiators across the MBR network. Hae was Medical Director and President of the Louisville Metabolic and Atherosclerosis Research Center, Inc. (L-MARC), which was acquired by MBR in 2025. He is a nationally recognized investigator for obesity, endocrinology, lipid disorders, cardiometabolic disease, and MASH/MASLD research.
  • Keith Horvath, MD

    Keith Horvath, MD, is an investigator with Monroe Biomedical Research in North Charleston, South Carolina. A board-certified surgeon with specialty training in cardiothoracic surgery, Dr. Horvath has decades of experience in cardiac and thoracic care, academic medicine, and clinical research. He earned his medical degree from the University of Chicago Pritzker School of Medicine and completed surgical training at Brigham and Women’s Hospital, with additional research training at Massachusetts General Hospital. His research background spans cardiovascular surgery, valve disease, CABG, atrial fibrillation, transfusion practices, renal protection, neuroprotection, and cardiac surgery outcomes. At MBR, he supports clinical research with a strong foundation in surgical expertise, patient care, and evidence-based medicine.
  • Rasheed Onafuye, MD

    Dr. Rasheed Onafuye is a psychiatrist and clinical researcher with extensive experience caring for adults with complex mental health, sleep, and metabolic conditions. At Monroe Biomedical Research, he serves as Principal Investigator and Sub-Investigator for trials. He is a key investigator for psychiatry, sleep medicine, addiction, CNS, and controlled-substance studies, and also supports obesity and chronic weight management research.

New at MBR

Move Research Forward With MBR

For Participants

Find a study near you

Browse currently enrolling studies in Monroe, Charleston, and Louisville.

For Sponsors & CROs

Connect With MBR's Team

Tell us about your research program.